Trial NCT01285557

View at ClinicalTrials.gov 
Org. Study IDs: TPU-S1303

Last trial update was posted on 2022-05-17

MeSH Interventions

Cisplatin Fluorouracil Tegafur

MeSH Conditions

Stomach Neoplasms

Other Conditions

Metastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal Junction

Stopping Reasons

Due to significant changes in investigational and clinical practice landscape of frontline advanced gastric cancer, which challenged viability of trial and increased use of modified chemotherapeutic triplets led to slow participant accrual in study.

Limitations And Caveats

Enrollment closure and study termination was due to significant changes in investigational and clinical practice landscape of frontline advanced gastric cancer, which challenged viability of trial and increased use of modified chemotherapeutic triplets led to slow participant accrual in the study. The decision to halt further accrual was not based on any safety or study quality concerns.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID